These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 6085528)
1. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia. Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG Trans Assoc Am Physicians; 1984; 97():268-74. PubMed ID: 6085528 [No Abstract] [Full Text] [Related]
2. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea. Dover GJ; Charache S; Boyer SH Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527 [No Abstract] [Full Text] [Related]
3. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea. Veith R; Galanello R; Papayannopoulou T; Stamatoyannopoulos G N Engl J Med; 1985 Dec; 313(25):1571-5. PubMed ID: 2415821 [TBL] [Abstract][Full Text] [Related]
5. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience. Rodgers GP Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375 [TBL] [Abstract][Full Text] [Related]
6. Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience. Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW Prog Clin Biol Res; 1989; 316B():281-93. PubMed ID: 2482498 [No Abstract] [Full Text] [Related]
7. Stimulation of fetal hemoglobin production by hydroxyurea in sickle cell anemia. Dover GJ; Charache S Prog Clin Biol Res; 1989; 316B():295-306. PubMed ID: 2482499 [No Abstract] [Full Text] [Related]
8. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW N Engl J Med; 1990 Apr; 322(15):1037-45. PubMed ID: 1690857 [TBL] [Abstract][Full Text] [Related]
9. Pharmacologic stimulation of Hb F in patients with sickle cell anemia. Galanello R; Veith R; Papayannopoulou T; Stamatoyannopoulos G Prog Clin Biol Res; 1985; 191():433-45. PubMed ID: 2413479 [No Abstract] [Full Text] [Related]
10. Modulation of HBF production by erythropoietin. Stamatoyannopoulos G; Umemura T; al-Khatti A; Spadaccino E; Abels RI; Fritsch EF; Papayannopoulou T Prog Clin Biol Res; 1989; 316B():269-80. PubMed ID: 2482497 [No Abstract] [Full Text] [Related]
11. Regulation of fetal hemoglobin synthesis by cell cycle specific drugs. Nathan DG Prog Clin Biol Res; 1985; 191():475-500. PubMed ID: 2413483 [No Abstract] [Full Text] [Related]
12. Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease. Dover GJ; Charache S Semin Oncol; 1992 Jun; 19(3 Suppl 9):61-6. PubMed ID: 1379374 [TBL] [Abstract][Full Text] [Related]